Care In Touch Home Health Agency | |
41829 Albrae Street, Suite 218, Fremont, California 94538 | |
(510) 651-8500 | |
Name | Care In Touch Home Health Agency |
---|---|
Location | 41829 Albrae Street, Suite 218, Fremont, California |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 59554 |
Ownership Type | Proprietary |
Service Area Zip Codes | 94002, 94005, 94010, 94014, 94015, 94022, 94025, 94041, 94044, 94061, 94063, 94065, 94066, 94080, 94086, 94087, 94089, 94102, 94103, 94105, 94107, 94108, 94109, 94110, 94112, 94114, 94115, 94116, 94117, 94118, 94121, 94122, 94123, 94124, 94127, 94131, 94132, 94134, 94301, 94305, 94306, 94402, 94502, 94523, 94531, 94536, 94538, 94539, 94541, 94544, 94545, 94549, 94550, 94552, 94555, 94560, 94564, 94565, 94577, 94578, 94586, 94587, 94601, 94603, 94605, 94606, 94610, 94618, 94619, 94621, 94702, 94703, 94708, 94801, 94804, 94806, 95032, 95035, 95051, 95070, 95111, 95112, 95116, 95117, 95120, 95121, 95122, 95123, 95126, 95127, 95128, 95129, 95135, 95136 |
NPI Number | 1437428802 |
Organization Name | CARE IN TOUCH HOME HEALTH AGENCY |
Address | 41829 Albrae St, Suite 112, Fremont, CA 94538 |
Phone Number | 510-651-8500 |
News Archive
Women who reach the menopause early have a doubled risk for coronary heart disease and stroke, study findings show.
In a review published in Signal Transduction and Targeted Therapy, researchers from Sichuan University have reviewed the available literature.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced results from its Phase IIb clinical trial of Serdaxin in major depressive disorder.
Scientists at the Swedish medical university Karolinska Institutet have developed a new DNA-sequencing method that is much cheaper than those currently in use in laboratories. They hope that this new method will make it possible to map disease genes in large patient groups, which in turn can mean quicker breakthroughs for new treatments for a wide variety of diseases.
› Verified 4 days ago
Quality Rating: |
News Archive
Women who reach the menopause early have a doubled risk for coronary heart disease and stroke, study findings show.
In a review published in Signal Transduction and Targeted Therapy, researchers from Sichuan University have reviewed the available literature.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced results from its Phase IIb clinical trial of Serdaxin in major depressive disorder.
Scientists at the Swedish medical university Karolinska Institutet have developed a new DNA-sequencing method that is much cheaper than those currently in use in laboratories. They hope that this new method will make it possible to map disease genes in large patient groups, which in turn can mean quicker breakthroughs for new treatments for a wide variety of diseases.
› Verified 4 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 99 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 100 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 98.8 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 99.3 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 96.4 | 96.4 |
News Archive
Women who reach the menopause early have a doubled risk for coronary heart disease and stroke, study findings show.
In a review published in Signal Transduction and Targeted Therapy, researchers from Sichuan University have reviewed the available literature.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced results from its Phase IIb clinical trial of Serdaxin in major depressive disorder.
Scientists at the Swedish medical university Karolinska Institutet have developed a new DNA-sequencing method that is much cheaper than those currently in use in laboratories. They hope that this new method will make it possible to map disease genes in large patient groups, which in turn can mean quicker breakthroughs for new treatments for a wide variety of diseases.
› Verified 4 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 72.7 | 79.6 |
How often patients got better at getting in and out of bed | 93.9 | 81.1 |
How often patients got better at bathing | 93.3 | 82.3 |
How often patients’ breathing improved | 92.8 | 82.8 |
How often patients’ wounds improved or healed after an operation | 86.7 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 83.7 | 75 |
How often home health patients had to be admitted to the hospital | 16.4 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 13.9 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 95.9 | 94 |
News Archive
Women who reach the menopause early have a doubled risk for coronary heart disease and stroke, study findings show.
In a review published in Signal Transduction and Targeted Therapy, researchers from Sichuan University have reviewed the available literature.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced results from its Phase IIb clinical trial of Serdaxin in major depressive disorder.
Scientists at the Swedish medical university Karolinska Institutet have developed a new DNA-sequencing method that is much cheaper than those currently in use in laboratories. They hope that this new method will make it possible to map disease genes in large patient groups, which in turn can mean quicker breakthroughs for new treatments for a wide variety of diseases.
› Verified 4 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | Not Available |
Health team communicated well with them | Not Available |
Health team discussed medicines, pain, and home safety | Not Available |
How patients rated overall care from agency | Not Available |
News Archive
Women who reach the menopause early have a doubled risk for coronary heart disease and stroke, study findings show.
In a review published in Signal Transduction and Targeted Therapy, researchers from Sichuan University have reviewed the available literature.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced results from its Phase IIb clinical trial of Serdaxin in major depressive disorder.
Scientists at the Swedish medical university Karolinska Institutet have developed a new DNA-sequencing method that is much cheaper than those currently in use in laboratories. They hope that this new method will make it possible to map disease genes in large patient groups, which in turn can mean quicker breakthroughs for new treatments for a wide variety of diseases.
› Verified 4 days ago
The patient survey data of Care In Touch Home Health Agency is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 83 | 88 |
Percent of patients who reported that their home health team communicated well with them | 82 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 85 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 84 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 69 | 78 |
News Archive
Women who reach the menopause early have a doubled risk for coronary heart disease and stroke, study findings show.
In a review published in Signal Transduction and Targeted Therapy, researchers from Sichuan University have reviewed the available literature.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced results from its Phase IIb clinical trial of Serdaxin in major depressive disorder.
Scientists at the Swedish medical university Karolinska Institutet have developed a new DNA-sequencing method that is much cheaper than those currently in use in laboratories. They hope that this new method will make it possible to map disease genes in large patient groups, which in turn can mean quicker breakthroughs for new treatments for a wide variety of diseases.
› Verified 4 days ago
Angelcare Home Health Services, Llc Location: 4450 Enterprise Street, Suite 101, Fremont, California 94538 Ratings: Phone: (646) 361-9817 | |
Professional Home Care Associates Location: 2296 Country Drive, Fremont, California 94536 Ratings: Phone: (510) 797-9299 | |
Warm Springs Home Health, Inc Location: 54 Whitney Place, Fremont, California 94539 Ratings: Phone: (510) 490-6988 | |
Noble Hospice & Home Health Care, Inc Location: 41305 Albrae Street, Fremont, California 94538 Ratings: Phone: (510) 683-9100 | |
Golden Angels Home Health Care Location: 43136 Christy Street, Suite 112, Fremont, California 94538 Ratings: NA Phone: (510) 683-4600 | |
We Care Home Care And Hospice, Inc. Location: 46723 Fremont Boulevard, Fremont, California 94538 Ratings: Phone: (510) 651-2100 |